PRaG 3.0 therapy for human epidermal growth factor receptor 2-positive metastatic pancreatic ductal adenocarcinoma: A case report.

Yue-Hong KongMei-Ling XuJun-Jun ZhangGuang-Qiang ChenZhi-Hui HongHong ZhangXiao-Xiao DaiYi-Fu MaXiang-Rong ZhaoChen-Yang ZhangRong-Zheng ChenPeng-Fei XingLi-Yuan Zhang

Published in: World journal of gastroenterology (2024)

PRaG 3.0 might be a novel strategy for HER2-positive metastatic PDAC patients who failed from previous first-line approach and even PD-1 immunotherapy but needs more data in prospective trials.

Keyphrases

epidermal growth factor receptor
squamous cell carcinoma
tyrosine kinase
small cell lung cancer
advanced non small cell lung cancer
endothelial cells
electronic health record
induced pluripotent stem cells
pluripotent stem cells
artificial intelligence
data analysis
deep learning